| Autor: |
Mark Stroh, Karen A. Autio, Matthias Will, Rachel Humphrey, Beiyao Zheng, Valentina Boni, James Strauss, Johanna C. Bendell, Luc R. Desnoyers, Amy Weise, Naiyer A. Rizvi, Bert H. O'Neil, Alexander I. Spira, Nataliya Volodymyrivna Uboha, Lori Carman, Anthony B. El-Khoueiry, Aung Naing, Hendrik-Tobias Arkenau |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
Journal of Clinical Oncology. 36:3071-3071 |
| ISSN: |
1527-7755
0732-183X |
| DOI: |
10.1200/jco.2018.36.15_suppl.3071 |
| Popis: |
3071Background: In single-agent trials, antibodies (Abs) targeting programmed cell death ligand 1 (PD-L1) improve survival in many cancers but are associated with immune-related toxicities (most co... |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
